RT, through increased neo-antigen formation and PDL-1 upregulation, has been found to have a synergistic effect when combined with checkpoint inhibitors for the treatment of solid tumors, leading to tumor regression as well as improved systemic and local tumor control [77,78,79]. Here, CD274 is linked to neoplasm.